UA7206A1 - Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату - Google Patents

Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату

Info

Publication number
UA7206A1
UA7206A1 UA4028642A UA4028642A UA7206A1 UA 7206 A1 UA7206 A1 UA 7206A1 UA 4028642 A UA4028642 A UA 4028642A UA 4028642 A UA4028642 A UA 4028642A UA 7206 A1 UA7206 A1 UA 7206A1
Authority
UA
Ukraine
Prior art keywords
cyclobutyl
chlorophenyl
dimethyl
producing
hydrochloride monohydrate
Prior art date
Application number
UA4028642A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Едвард Джеффері Джеймс
Вайбрау Дерек
Original Assignee
Дзе Бутс Компані Плс
Дзе Бутс Компани ПЛС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10589895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA7206(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дзе Бутс Компані Плс, Дзе Бутс Компани ПЛС filed Critical Дзе Бутс Компані Плс
Publication of UA7206A1 publication Critical patent/UA7206A1/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
UA4028642A 1985-12-17 1986-12-15 Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату UA7206A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858531071A GB8531071D0 (en) 1985-12-17 1985-12-17 Therapeutic compound

Publications (1)

Publication Number Publication Date
UA7206A1 true UA7206A1 (uk) 1995-06-30

Family

ID=10589895

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4028642A UA7206A1 (uk) 1985-12-17 1986-12-15 Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату

Country Status (34)

Country Link
US (2) US4929629A (2)
EP (1) EP0230742B1 (2)
JP (1) JPS62155240A (2)
KR (1) KR940008913B1 (2)
CN (1) CN1016245B (2)
AT (1) ATE56942T1 (2)
AU (1) AU601167B2 (2)
CA (1) CA1266278A (2)
CS (1) CS259545B2 (2)
DD (1) DD263050A5 (2)
DE (1) DE3674570D1 (2)
DK (1) DK170770B1 (2)
EG (1) EG17770A (2)
ES (1) ES2018163T4 (2)
FI (1) FI90413C (2)
GB (1) GB8531071D0 (2)
GE (1) GEP19970812B (2)
GR (1) GR3001069T3 (2)
HU (1) HU201901B (2)
IE (1) IE59429B1 (2)
IL (1) IL80934A (2)
IN (1) IN163129B (2)
LU (1) LU90865I2 (2)
MX (1) MX4684A (2)
NL (1) NL300065I1 (2)
NO (2) NO165540C (2)
NZ (1) NZ218578A (2)
PH (1) PH22481A (2)
PL (1) PL149519B1 (2)
PT (1) PT83958B (2)
SU (1) SU1443796A3 (2)
UA (1) UA7206A1 (2)
YU (1) YU46033B (2)
ZA (1) ZA869078B (2)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
AU4542993A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
AU4542893A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
GB9619757D0 (en) 1996-09-21 1996-11-06 Knoll Ag Chemical process
GB9619961D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
IL144390A0 (en) * 1999-01-20 2002-05-23 Knoll Gmbh Method to aid smoking cessation
BG65170B1 (bg) * 1999-03-17 2007-05-31 Knoll Gmbh Използване на n-заместени производни на 1-[1-(4-хлорофенил)циклобутил]-3-метилбутиламин за производство на лекарство за лечение на разстройства при храненето
IL145238A0 (en) * 1999-03-19 2002-06-30 Knoll Gmbh Treatment of osteoarthritis
MXPA01009470A (es) * 1999-03-19 2004-03-19 Knoll Gmbh Tratamiento de ciertos canceres asociados con el aumento de peso.
WO2000056311A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Control of metabolism
AU3894500A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Prevention of cardiovascular disease
WO2000056321A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Treatment of hyperactivity disorders
EP1169029B1 (en) * 1999-03-19 2005-05-04 Abbott GmbH & Co. KG Use of sibutramine or its derivative for the treatment of sleep disorders
AU3896900A (en) * 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of pain
US6403650B1 (en) 1999-03-19 2002-06-11 Knoll Pharmaceutical Company Treatment of pulmonary hypertension
WO2000056319A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Treatment of orthostatic hypotension
US6803387B1 (en) 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
WO2000056309A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Method of treating sexual dysfunction
WO2000056310A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Treatment of chronic fatigue syndrome
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6380200B1 (en) 1999-12-07 2002-04-30 Pfizer, Inc. Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US6232347B1 (en) 2000-03-17 2001-05-15 Knoll Pharmaceutical Company Treatment of osteoarthritis
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
NZ534757A (en) * 2002-03-12 2006-07-28 Merck & Co Inc Substituted amides
JP4278652B2 (ja) * 2002-10-05 2009-06-17 ハンミ ファーム． シーオー．， エルティーディー． 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物
KR100536750B1 (ko) * 2002-10-05 2005-12-16 한미약품 주식회사 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는약학 조성물
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
GB0310361D0 (en) * 2003-05-06 2003-06-11 Cipla Ltd Pharmaceutical compound
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
WO2006056845A1 (en) * 2004-11-23 2006-06-01 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
WO2006073292A1 (en) 2005-01-06 2006-07-13 Cj Corporation Inorganic acid salts of sibutramine
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
KR100781882B1 (ko) * 2005-07-12 2007-12-05 주식회사유한양행 시부트라민을 함유하는 약제학적 조성물
WO2007015162A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
EP1938811A4 (en) * 2005-09-22 2008-12-17 Eisai R&D Man Co Ltd MEDICAL COMPOSITION FOR THE TREATMENT OF BULAMINE AND BULAMIC DEPRESSIONS
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2402581T3 (es) * 2006-02-23 2013-05-06 Pfizer Limited Piperidinoilpirrolidinas como agonistas del receptor de melanocortina tipo 4
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008034142A2 (en) 2006-09-15 2008-03-20 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cycloalkylmethylamines
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
MX2009004314A (es) 2006-11-13 2009-05-05 Pfizer Prod Inc Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos.
US20080182851A1 (en) * 2006-11-20 2008-07-31 Glenmark Pharmaceuticals S.A. Acetylene derivatives as stearoyl coa desaturase inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US20080221057A1 (en) * 2007-02-16 2008-09-11 Wyeth Secreted protein ccdc80 regulates adipocyte differentiation
WO2008124122A1 (en) * 2007-04-09 2008-10-16 Scidose, Llc Combinations of statins and anti-obesity agent and glitazones
EP2131835A1 (en) * 2007-04-09 2009-12-16 Scidose, Llc Combinations of statins and anti-obesity agent
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
JP5530438B2 (ja) * 2008-08-06 2014-06-25 ファイザー・リミテッド Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
EP2395987A1 (en) 2009-02-12 2011-12-21 Coöperatieve Mirzorg U.A., Arnhem Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
EA021983B1 (ru) 2009-11-02 2015-10-30 Пфайзер Инк. Производные диоксабицикло[3.2.1]октан-2,3,4-триола
WO2011122524A1 (ja) 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
SA111320581B1 (ar) 2010-07-06 2014-06-17 استرازينيكا ايه بي مركبات (3-(4-(أمينو ميثيل ) فينوكسي أو فينيل ثيو) أزيتيدين -1- يل) (5- فينيل -1، 3، 4- أوكسا ديازول -2- يل) ميثانون
PL3400944T3 (pl) 2010-11-04 2020-11-16 Albireo Ab Inhibitory ibat w leczeniu chorób wątroby
JP6097695B2 (ja) 2010-11-08 2017-03-15 アルビレオ アクチエボラグ Ｉｂａｔ阻害剤および胆汁酸結合剤を含む薬学的組み合わせ
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
WO2014036528A2 (en) 2012-08-31 2014-03-06 Ixchel Pharma, Llc Agents useful for treating obesity, diabetes and related disorders
CN110372522B (zh) * 2019-07-30 2020-10-02 南京工业大学 一种从含有戊二胺的固相中汽提回收戊二胺的方法
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1124485B (de) * 1960-02-12 1962-03-01 Hoechst Ag Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
SE7600674L (sv) * 1975-02-05 1976-08-06 Rohm & Haas Fungicider
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
US4443449A (en) * 1981-04-06 1984-04-17 The Boots Company Limited Arylcyclobutylalkylamines and anti-depression composition and methods using same
GB2115409B (en) * 1982-02-24 1985-08-07 Zyma Sa Novel crystal modifications of (+)-catechin
DK101683A (da) * 1982-03-12 1983-09-13 Duphar Int Res Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf
IE56001B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylmethylamine compounds
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity

Also Published As

Publication number Publication date
EP0230742B1 (en) 1990-09-26
PT83958A (en) 1987-01-01
JPS62155240A (ja) 1987-07-10
NO165540C (no) 1991-02-27
IE863102L (en) 1987-06-17
NO865093L (no) 1987-06-18
EP0230742A1 (en) 1987-08-05
EG17770A (en) 1991-03-30
FI865030L (fi) 1987-06-18
JPH0144176B2 (2) 1989-09-26
FI865030A0 (fi) 1986-12-10
DK585786D0 (da) 1986-12-05
SU1443796A3 (ru) 1988-12-07
NO165540B (no) 1990-11-19
NO2005022I1 (no) 2005-10-03
IE59429B1 (en) 1994-02-23
LU90865I2 (fr) 2002-02-18
CS259545B2 (en) 1988-10-14
AU6644286A (en) 1987-06-18
GEP19970812B (en) 1997-02-10
DK170770B1 (da) 1996-01-15
ES2018163T4 (es) 2012-06-14
MX4684A (es) 1993-12-01
NO865093D0 (no) 1986-12-16
PL149519B1 (en) 1990-02-28
CN1016245B (zh) 1992-04-15
PT83958B (pt) 1989-05-12
CN86108547A (zh) 1987-08-19
IN163129B (2) 1988-08-13
YU205086A (en) 1987-12-31
GR3001069T3 (en) 1992-03-20
HUT45964A (en) 1988-09-28
ES2018163B3 (es) 1991-04-01
ZA869078B (en) 1987-07-29
CS930586A2 (en) 1988-02-15
IL80934A (en) 1990-07-26
DK585786A (da) 1987-06-18
US4929629A (en) 1990-05-29
DE3674570D1 (de) 1990-10-31
NL300065I1 (nl) 2001-12-01
KR870005961A (ko) 1987-07-08
GB8531071D0 (en) 1986-01-29
PL263020A1 (en) 1988-05-12
HU201901B (en) 1991-01-28
NZ218578A (en) 1989-04-26
CA1266278A (en) 1990-02-27
YU46033B (sh) 1992-12-21
DD263050A5 (de) 1988-12-21
AU601167B2 (en) 1990-09-06
FI90413C (fi) 1994-02-10
PH22481A (en) 1988-09-12
ATE56942T1 (de) 1990-10-15
KR940008913B1 (ko) 1994-09-28
US5068440A (en) 1991-11-26
FI90413B (fi) 1993-10-29

Similar Documents

Publication Publication Date Title
UA7206A1 (uk) Спосіб одержання гідрохлориду n,n-діметіл-1-[1-(4-хлорфеніл)-циклобутіл]-3-метілбутіламіна у вигляді моногідрату
DK266485A (da) Semipermeabel sulfoneret kompositpolysulfonmembran samt fremgangsmaade til fremstilling deraf
ES2023976B3 (es) Procedimiento para el enriquecimiento de helio.
DE3665886D1 (en) Process for the electrodeposition of composite tin-graphite or tin-lead graphite layers, and baths used therefor
DE3668268D1 (de) Verwendung von cis-n-(2-aminocycloaliphatische) benzen acetamid und benzamid zur herstellung von antikrampfmittel.
NO864554D0 (no) Flytende oppvaskmiddelblanding for haandvask i kaldt vann.
DK354188D0 (da) Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
IT1155090B (it) Struttura multistratificata per complesso di elettrodo e membrana e procedimento di elettrolisi usante il medesimo
EP0252357A3 (en) Process for the preparation of (4-hydroxyphenyl)-4-hydroxy-benzoate, and its use
NO167047C (no) Katode til bruk i hydrogenutviklende elektrokjemiske prosesser, samt fremgangsmaate til fremstilling av katoden.
Gilad et al. Measurement of the 16O (pi+, pi 0p) reaction
NO862506L (no) Steroido(3,2-c)pyrazoler med antiandrogen virkning og fremgangsmaate for deres fremstilling.
Wheeler Stratigraphy and sedimentology of the Tensleep sandstone, southeast Bighorn Basin, Wyoming
IT8767940A0 (it) Procedimento microbiologico per lapreparazione di 9 alfa -idrossi4-androstene-3,17 dione
IT8025482A0 (it) Membrana modificata morfologicamente ed uso della stessa in procedimenti di elettrolisi.
IT1136191B (it) Procedimento per la preparazione di lievito naturale allo stato granulato fine trasportabile e conservabile nel tempo
IT8468046A0 (it) Procedimento per la preparazione di monocarburo di tungsteno mediante diffusione di gas contenenti idrocarburi
ES489117A1 (es) Metodo para la preparacion de benzaldehido puro en presenciade agua
IT1212160B (it) Dispositivo e procedimento per laperforazione di cartucce di gas
IT8467251A1 (it) Procedimento catalitico per la decarbossilazione accelerata di carbonato di calcio e miscela utilizzata nel procedimento.
DE58904702D1 (de) Beta-phenoxyethylamine und deren verwendung zur herstellung von farbstoffen.
IT1194342B (it) Processo per la preparazione di '-(1-metil-4-piperidilidene)-4,9-diidrotieno(2,3-c)-2-benzotiepina e relativo idrogeno(+)tartrato
Hinohara Tracheostomy: Indications and Post-operative Care
IT8719519A0 (it) Procedimento ed apparecchiatura per la dispersione di un gas di nucleazione in un componente liquido di una miscela espandibile.
RO100572A2 (ro) Compozitie biocida si procedeu de preparare a acesteia